Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Select Medical Holdings (SEM) Revenue (2018 - 2026)

Select Medical Holdings (SEM) has disclosed Revenue for 9 consecutive years, with $1.4 billion as the latest value for Q1 2026.

  • For Q1 2026, Revenue rose 5.05% year-over-year to $1.4 billion; the TTM value through Mar 2026 reached $5.5 billion, up 5.79%, while the annual FY2025 figure was $5.5 billion, 5.12% up from the prior year.
  • Revenue hit $1.4 billion in Q1 2026 for Select Medical Holdings, up from $1.4 billion in the prior quarter.
  • Across five years, Revenue topped out at $1.6 billion in Q1 2022 and bottomed at -$142.9 million in Q4 2022.
  • Average Revenue over 5 years is $1.3 billion, with a median of $1.3 billion recorded in 2024.
  • Year-over-year, Revenue crashed 109.16% in 2022 and then skyrocketed 952.41% in 2023.
  • Select Medical Holdings' Revenue stood at -$142.9 million in 2022, then surged by 952.41% to $1.2 billion in 2023, then grew by 7.75% to $1.3 billion in 2024, then increased by 6.41% to $1.4 billion in 2025, then rose by 1.78% to $1.4 billion in 2026.
  • According to Business Quant data, Revenue over the past three periods came in at $1.4 billion, $1.4 billion, and $1.4 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.